Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Introduction

GlobalData, the industry analysis specialist, has released its new report, “Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Vitiligo Therapeutics market. The report identifies the key trends shaping and driving the global Vitiligo Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Vitiligo Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Vitiligo Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Vitiligo Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Vitiligo Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Vitiligo Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Vitiligo Therapeutics market

Highlights

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Vitiligo Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Vitiligo Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Vitiligo Therapeutics market landscape? – Identify, understand and capitalize.

Report Highlights
Clinuvel Pharmaceuticals
Switch Biotech
Dermira
[Studien Infos ausblenden]

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Vitiligo Therapeutics - Introduction 7
2.1 Disease Overview 7
2.2 Epidemiology 9
2.3 Etiology and Pathophysiology 9
2.3.1 Etiology of Vitiligo 9
2.3.2 Pathophysiology of Vitiligo 9
2.4 Signs and Symptoms 10
2.5 Diagnosis 11
2.6 Treatment and Management Options 11
2.6.1 Medical Therapies 11
2.6.2 Surgical Therapies 12
2.6.3 Additional Therapies 13
2.7 GlobalData Pipeline Report Guidance 14
3 Vitiligo Therapeutics - Market Characterization 15
3.1 Vitiligo Therapeutics Market Size (2006-2011) - Global 15
3.2 Vitiligo Therapeutics Market Forecast (2011-2019) - Global 17
3.3 Vitiligo Therapeutics Market Size (2006-2011) - The US 18
3.4 Vitiligo Therapeutics Market Forecast (2011-2019) - The US 19
3.5 Vitiligo Therapeutics Market Size (2006-2011) - France 20
3.6 Vitiligo Therapeutics Market Forecast (2011-2019) - France 21
3.7 Vitiligo Therapeutics Market Size (2006-2011) - Germany 22
3.8 Vitiligo Therapeutics Market Forecast (2011-2019) - Germany 23
3.9 Vitiligo Therapeutics Market Size (2006-2011) - Italy 24
3.10 Vitiligo Therapeutics Market Forecast (2011-2019) - Italy 25
3.11 Vitiligo Therapeutics Market Size (2006-2011) - Spain 26
3.12 Vitiligo Therapeutics Market Forecast (2011-2019) - Spain 27
3.13 Vitiligo Therapeutics Market Size (2006-2011) - The UK 28
3.14 Vitiligo Therapeutics Market Forecast (2011-2019) - The UK 29
3.15 Vitiligo Therapeutics Market Size (2006-2011) - Japan 30
3.16 Vitiligo Therapeutics Market Forecast (2011-2019) - Japan 31
3.17 Drivers and Barriers for the Vitiligo Therapeutics Market 32
3.17.1 Drivers for the Vitiligo Therapeutics Market 32
3.17.2 Barriers for the Vitiligo Therapeutics Market 32
3.18 Opportunity and Unmet Need 33
3.19 Key Takeaway 34
4 Vitiligo Therapeutics - Competitive Assessment 35
4.1 Overview 35
4.2 Strategic Competitor Assessment 35
4.3 Product Profile for the Major Marketed Products in the Vitiligo Therapeutics Market 36
4.3.1 Topical Corticosteroids 36
4.3.2 Topical Immunomodulators 37
4.3.3 Methoxsalen 39
4.4 Key Takeaway 39
5 Vitiligo Therapeutics - Pipeline Assessment 40
5.1 Overview 40
5.2 Strategic Pipeline Assessment 40
5.3 Vitiligo Therapeutics - Pipeline Analysis by Clinical Phase of Development 40
5.3.1 Vitiligo Therapeutics - Phase III Clinical Pipeline 41
5.3.2 Vitiligo Therapeutics - Phase II Clinical Pipeline 41
5.3.3 Vitiligo Therapeutics - Preclinical Phase Pipeline 41
5.4 Vitiligo Therapeutics - Pipeline by Mechanism of Action 42
5.5 Technology Trends Analytical Framework 43
5.6 Vitiligo Therapeutics - Most Promising Drugs in Clinical Development 44
5.7 Most Promising Drug Profiles 44
5.7.1 Scenesse (afamelanotide) 44
5.8 Key Takeaway 45
6 Vitiligo Therapeutics - Clinical Trials Mapping 46
6.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 46
6.2 Clinical Trials by Phase of Clinical Development 47
6.3 Clinical Trials by Trial Status 48
6.4 Prominent Sponsors 49
6.5 Clinical Trials by Sponsors 50
6.6 Top Companies Participating in Vitiligo Therapeutics Clinical Trials 50
7 Vitiligo Therapeutics - Strategic Assessment 51
7.1 Key Events Impacting the Future Market 51
7.2 Future Market Competition Scenario 52
8 Vitiligo Therapeutics - Future Players 53
8.1 Introduction 53
8.2 Company Profiles 54
8.2.1 Clinuvel Pharmaceuticals 54
8.2.2 Switch Biotech 55
8.2.3 Dermira 55
8.3 Key Takeaway 56
9 Vitiligo Therapeutics - Licensing & Partnership Deals 57
10 Vitiligo Therapeutics - Appendix 58
10.1 Definitions 58
10.2 Acronyms 58
10.3 Research Methodology 58
10.3.1 Coverage 59
10.3.2 Secondary Research 59
10.3.3 Forecasting 59
10.3.4 Primary Research 61
10.3.5 Expert Panel Validation 62
10.4 Contact Us 62
10.5 Disclaimer 62
10.6 Bibliography 63
[Inhaltsverzeichnis ausblenden]

1.1 List of Tables
Table 1: Characteristics of Various Types of Vitiligo 7
Table 2: Vitiligo Prevalence in Seven Major Markets 9
Table 3: Vitiligo Therapeutics Market, Global, Revenue ($m), 2006-2011 16
Table 4: Vitiligo Therapeutics Market, Global, Forecast ($m), 2011-2019 17
Table 5: Vitiligo Therapeutics Market, The US, Revenue ($m), 2006-2011 18
Table 6: Vitiligo Therapeutics Market, The US, Forecast ($m), 2011-2019 19
Table 7: Vitiligo Therapeutics Market, France, Revenue ($m), 2006-2011 20
Table 8: Vitiligo Therapeutics Market, France, Forecast ($m), 2011-2019 21
Table 9: Vitiligo Therapeutics Market, Germany, Revenue ($m), 2006-2011 22
Table 10: Vitiligo Therapeutics Market, Germany, Forecast ($m), 2011-2019 23
Table 11: Vitiligo Therapeutics Market, Italy, Revenue ($m), 2006-2011 24
Table 12: Vitiligo Therapeutics Market, Italy, Forecast ($m), 2011-2019 25
Table 13: Vitiligo Therapeutics Market, Spain, Revenue ($m), 2006-2011 26
Table 14: Vitiligo Therapeutics Market, Spain, Forecast ($m), 2011-2019 27
Table 15: Vitiligo Therapeutics Market, The UK, Revenue ($m), 2006-2011 28
Table 16: Vitiligo Therapeutics Market, The UK, Forecast ($m), 2011-2019 29
Table 17: Vitiligo Therapeutics Market, Japan, Revenue ($m), 2006-2011 30
Table 18: Vitiligo Therapeutics Market, Japan, Forecast ($m), 2011-2019 31
Table 19: Vitiligo Therapeutics Market, Phase III Pipeline, 2011 41
Table 20: Vitiligo Therapeutics Market, Phase II Pipeline, 2011 41
Table 21: Vitiligo Therapeutics Market, Pre-clinical and Discovery Phase Pipeline, 2011 41
Table 22: Vitiligo Therapeutics Market, Global, Most Promising Drugs in Clinical Development, 2011 44
Table 23: Vitiligo Therapeutics, Global, Clinical Trials, 2011 46
Table 24: Vitiligo Therapeutics, Global, Clinical Trials by Phase, 2011 47
Table 25: Vitiligo Therapeutics, Global, Clinical Trials by Status of Development, 2011 48
Table 26: Vitiligo Therapeutics, Global, Prominent Sponsors, 2011 49
Table 27: Vitiligo Therapeutics, Global, Overall Sponsors, 2011 50
Table 28: Vitiligo Therapeutics, Global, Top Companies by Phase, 2011 50
Table 29: Clinuvel Pharmaceuticals - Vitiligo, Pipeline, 2011 54
Table 30: Switch Biotech - Vitiligo, Pipeline, 2011 55
Table 31: Dermira - Vitiligo, Pipeline, 2011 55
Table 32: Vitiligo Therapeutics, Global, Deals - 2011 57
1.2 List of Figures
Figure 1: Graphic Presentation of Vitiligo 8
Figure 2: Vitiligo Therapeutics Market, Global, Revenue ($m), 2006-2011 15
Figure 3: Vitiligo Therapeutics Market, Global, Forecast ($m), 2011-2019 17
Figure 4: Vitiligo Therapeutics Market, The US, Revenue ($m), 2006-2011 18
Figure 5: Vitiligo Therapeutics Market, The US, Forecast ($m), 2011-2019 19
Figure 6: Vitiligo Therapeutics Market, France, Revenue ($m), 2006-2011 20
Figure 7: Vitiligo Therapeutics Market, France, Forecast ($m), 2011-2019 21
Figure 8: Vitiligo Therapeutics Market, Germany, Revenue ($m), 2006-2011 22
Figure 9: Vitiligo Therapeutics Market, Germany, Forecast ($m), 2011-2019 23
Figure 10: Vitiligo Therapeutics Market, Italy, Revenue ($m), 2006-2011 24
Figure 11: Vitiligo Therapeutics Market, Italy, Forecast ($m), 2011-2019 25
Figure 12: Vitiligo Therapeutics Market, Spain, Revenue ($m), 2006-2011 26
Figure 13: Vitiligo Therapeutics Market, Spain, Forecast ($m), 2011-2019 27
Figure 14: Vitiligo Therapeutics Market, The UK, Revenue ($m), 2006-2011 28
Figure 15: Vitiligo Therapeutics Market, The UK, Forecast ($m), 2011-2019 29
Figure 16: Vitiligo Therapeutics Market, Japan, Revenue ($m), 2006-2011 30
Figure 17: Vitiligo Therapeutics Market, Japan, Forecast ($m), 2011-2019 31
Figure 18: Opportunity and Unmet Need in the Vitiligo Therapeutics Market 33
Figure 19: Strategic Competitor Assessment of the Marketed Products in Vitiligo Therapeutics, 2011 36
Figure 20: Vitiligo Therapeutics Pipeline by Phase of Clinical Development, 2011 41
Figure 21: Vitiligo Therapeutics Market, Global, Pipeline by Mechanism of Action (%), 2011 42
Figure 22: Technology Trends Analytics Framework, 2011 43
Figure 23: Technology Trends Analytics Framework - Description, 2011 44
Figure 24: Vitiligo Therapeutics, Global, Clinical Trials by Country, 2011 46
Figure 25: Vitiligo Therapeutics, Global, Clinical Trials by Phase (%), 2011 47
Figure 26: Vitiligo Therapeutics, Global, Clinical Trials by Status of Development (%), 2011 48
Figure 27: Vitiligo Therapeutics, Global, Prominent Sponsors (%), 2011 49
Figure 28: Vitiligo Therapeutics, Global, Overall Sponsors (%), 2011 50
Figure 29: Vitiligo Therapeutics Market, Drivers and Restraints, 2011 51
Figure 30: Implications for Future Market Competition in the Vitiligo Therapeutics Market, 2011 52
Figure 31: Vitiligo Therapeutics Market, Global, Future Players, 2011 53
Figure 32: GlobalData Market Forecasting Model 61
[Tabellenverzeichnis ausblenden]